Clinical Trials by University - Washington

Paid Clinical Trials and Focus Groups by Category

Find Paid Clinical Trials

Find Paid Clinical Trials All Categories ... University Studies » ... United States » ... Washington


  • Study of Cimzia for the Treatment of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Intervention:   Drug: Cimzia
    Sponsors:   University of Washington;   UCB, Inc.;   University of Pennsylvania
    Not yet recruiting - verified March 2010
  • The Community Youth Development Study: A Test of Communities That Care

    Conditions:   Substance Abuse;   Juvenile Delinquency;   Sexual Behavior
    Intervention:   Behavioral: Communities That Care
    Sponsors:   University of Washington;   National Institute on Drug Abuse (NIDA)
    Enrolling by invitation - verified March 2010
  • Using Diffuse Noxious Inhibitory Control (DNIC) to Predict Acupuncture Therapy Outcome: A Pilot Study

    Condition:   Pain
    Intervention:   Other: Acupuncture
    Sponsors:   University of Washington;   Bastyr University
    Recruiting - verified March 2010
  • Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection

    Conditions:   HIV;   HIV Infections
    Intervention:  
    Sponsor:   George Washington University
    Recruiting - verified March 2010
  • Healthy Homes/Healthy Kids_5-9

    Conditions:   Obesity;   Injury
    Interventions:   Behavioral: Healthy Eating/Physical Activity;   Behavioral: Safety/Injury Prevention
    Sponsors:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Washington;   University of Minnesota School of Public Health
    Not yet recruiting - verified March 2010
  • Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines

    Conditions:   Smoking;   Smoking Cessation
    Interventions:   Drug: Nicotine patch;   Drug: Nicotine polacrilex;   Other: Adherence coaching
    Sponsors:   University of Wisconsin, Madison;   Wisconsin Department of Health and Family Services;   Free and Clear, Inc.;   National Cancer Institute (NCI)
    Not yet recruiting - verified March 2010
  • Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

    Condition:   Sickle Cell Disease
    Intervention:   Drug: Lexiscan
    Sponsors:   Dana-Farber Cancer Institute;   Brigham and Women's Hospital;   Children's Hospital Boston;   Washington University School of Medicine;   LaJolla Institute for Allergy and Immunology;   National Heart, Lung, and Blood Institute (NHLBI)
    Not yet recruiting - verified March 2010
  • Treating PTSD in Patients With Borderline Personality Disorder

    Conditions:   Stress Disorders, Post-Traumatic;   Borderline Personality Disorder;   Suicide;   Self-Injurious Behavior
    Interventions:   Behavioral: Dialectical Behavior Therapy;   Behavioral: PTSD Protocol
    Sponsors:   University of Washington;   National Institute of Mental Health (NIMH)
    Active, not recruiting - verified March 2010
  • A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children

    Condition:   Infections With Soil-Transmitted Helminths (STH)
    Intervention:   Drug: Albendazole
    Sponsors:   University Ghent;   World Health Organization;   Department of Virology, Parasitology and Immunology,Ghent University, Faculty of Veterinary Medicine,Belgium;   Department of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland;   Department of Microbiology, Immunology, and Tropical Medicine, George Washington University Medical Center, Washington DC, USA;   Division of Livestock Industries, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Australia;   School of Biology, University of Nottingham, Notthingham, UK;   Queensland Institute for Medical Research, University of Queensland, Herston, Australia
    Active, not recruiting - verified March 2010
  • Azacitidine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant

    Conditions:   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With T(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With T(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With T(8;21)(q22;q22);   Childhood Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes
    Interventions:   Drug: azacitidine;   Drug: gemtuzumab ozogamicin
    Sponsor:   Fred Hutchinson Cancer Research Center
    Not yet recruiting - verified March 2010
  • Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer

    Condition:   Pancreatic Cancer
    Intervention:   Drug: Gemcitabine and Pazopanib
    Sponsor:   Washington University School of Medicine
    Not yet recruiting - verified March 2010
  • Alzheimer's Disease Neuroimaging Initiative Grand Opportunity

    Conditions:   Mild Cognitive Impairment;   Alzheimer's Disease
    Intervention:  
    Sponsors:   Alzheimer's Disease Cooperative Study (ADCS);   National Institute on Aging (NIA);   National Institutes of Health (NIH)
    Not yet recruiting - verified March 2010
  • Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

    Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy
    Interventions:   Drug: SB-509;   Other: Saline
    Sponsors:   Sangamo Biosciences;   Juvenile Diabetes Research Foundation
    Recruiting - verified March 2010
  • A Randomized Prospective Trial of Total Knee Arthroplasty Options Comparing Standard Knee Cutting Guides and MRI Generated Patient Specific Custom Cutting Guides

    Condition:   Osteoarthritis of the Knee.
    Intervention:   Other: Instrument
    Sponsors:   Washington University School of Medicine;   Biomet, Inc.
    Enrolling by invitation - verified March 2010
  • e-Care for Heart Wellness

    Condition:   CVD
    Intervention:   Behavioral: Dietician electonic support
    Sponsors:   Group Health Cooperative;   National Heart, Lung, and Blood Institute (NHLBI)
    Not yet recruiting - verified February 2010
  • Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Conditions:   Accelerated Phase Chronic Myelogenous Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With T(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With T(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With T(8;21)(q22;q22);   Atypical Chronic Myeloid Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   De Novo Myelodysplastic Syndromes;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Myelodysplastic/Myeloproliferative Disease, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Noncontiguous Stage II Adult Burkitt Lymphoma;   Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;   Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma;   Noncontiguous Stage II Adult Lymphoblastic Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Mantle Cell Lymphoma;   Noncontiguous Stage II Marginal Zone Lymphoma;   Noncontiguous Stage II Small Lymphocytic Lymphoma;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes;   Splenic Marginal Zone Lymphoma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Adult Burkitt Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Diffuse Small Cleaved Cell Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult Immunoblastic Large Cell Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Marginal Zone Lymphoma;   Stage III Multiple Myeloma;   Stage III Small Lymphocytic Lymphoma;   Stage IV Adult Burkitt Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult Immunoblastic Large Cell Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Marginal Zone Lymphoma;   Stage IV Small Lymphocytic Lymphoma
    Interventions:   Drug: plerixafor;   Biological: filgrastim;   Procedure: peripheral blood stem cell transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation
    Sponsor:   Fred Hutchinson Cancer Research Center
    Not yet recruiting - verified February 2010
  • Investigating the Needs of Childhood Cancer Survivors: The Unreported Experience

    Condition:   Childhood Cancer
    Intervention:   Other: Needs Assessment Survey of Adult Childhood Cancer Survivors
    Sponsors:   St. Jude Children's Research Hospital;   National Cancer Institute (NCI)
    Not yet recruiting - verified February 2010
  • Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

    Condition:   Hemangioma
    Interventions:   Drug: Prednisolone (Corticosteroid);   Drug: Propanolol;   Drug: Placebo
    Sponsor:   Seattle Children's Hospital
    Not yet recruiting - verified February 2010

Main Menu

Find Clinical Trials